We Can Help

The costs of mesothelioma can be overwhelming. They can include income loss, expensive treatments that may not be covered by health insurance, plus pain and suffering for you and for your family. Because the disease is preventable – and because it is usually caused by someone else’s negligence – legal options may be available to help regain these costs. Asbestos lawyers focus their practice on knowledgeably and effectively bringing to justice companies that exposed employees and the public to asbestos products. A mesothelioma attorney can help you consider your options and file a claim against the company responsible for your asbestos-related illness. More than one company may be responsible. A mesothelioma attorney identifies all companies at fault. Mesothelioma lawsuits have helped thousands of people receive financial assistance. A lawsuit can result in much-needed money to help reduce financial hardships during an illness and can also provide a more stable future for your loved ones. A lawyer specializing in asbestos litigation can help you seek compensation for expenses related to illness caused by asbestos exposure.

Lurbinectedin Clinical Trial is Showing Promising Results for Mesothelioma Patients

Researchers have created a new compound that could potentially help mesothelioma patients. Lurbinectedin is a synthetic material that can stop the growth of mesothelioma and other cancers. It works by blocking cytokine transcription in tumor cells. Cytokine transcription is the copying of DNA to allow the passing of the genetic information out of the cell.



Dendritic Cell Therapy Could be used to Treat Mesothelioma

Immunotherapy is a blossoming field that is becoming more advanced. Instead of other treatments that kill healthy cells in addition to killing cancerous cells, immunotherapy uses the body’s immune system to fight cancer cells, leaving healthy non-cancerous cells intact. It is a better treatment because it is very effective, more efficient, and is easier on



Less than Half of Cancer Patients Eligible for Immunotherapy Treatments

In late 2017, the FDA approved Keytruda (pembrolizumab) as an immunotherapy treatment for cancer.  It’s typically used to treat inoperable metastatic non-small cell lung cancer and melanoma but it has also been approved by the FDA to treat any unresectable or metastatic solid tumor, such as those found in mesothelioma. Immunotherapy is a type of



Using Keytruda for Mesothelioma May Become a Reality

The U.S. Food and Drug Administration recently upgraded its approval of pembrolizumab (Keytruda) for metastatic non-small cell lung cancer, inching it closer to becoming an accepted treatment option for pleural mesothelioma. Pembrolizumab, produced by pharmaceutical giant Merck & Co., also is marketed as Keytruda. The FDA’s announcement last week converted its previous “accelerated” approval in…

The post Using Keytruda for Mesothelioma May Become a Reality appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.


FDA Approves Keytruda For A New Type of Cancer

The U.S. Food and Drug Administration (FDA) has approved the drug Keytruda for patients with head and neck squamous cell carcinoma (HNSCC). […]

FDA-Approved Keytruda Treatment Could Help Mesothelioma Patients

Recently, the FDA approved Merck immunotherapy drug Keytruda for treatment in non-small cell lung cancer and is bringing hope to mesothelioma patients. […]

Can Opdivo Drug Be Good News for Mesothelioma Patients?

Expanded approved use of new lung cancer drug Opdivo could give malignant pleural mesothelioma patients hope. […]